Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Change in Acquisitions & Divestments (2024 - 2025)

Historic Change in Acquisitions & Divestments for Immunome (IMNM) over the last 2 years, with Q3 2025 value amounting to $125.0 million.

  • Immunome's Change in Acquisitions & Divestments rose 31666.67% to $125.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $285.0 million, marking a year-over-year change of. This contributed to the annual value of $155.0 million for FY2024, which is N/A changed from last year.
  • Per Immunome's latest filing, its Change in Acquisitions & Divestments stood at $125.0 million for Q3 2025, which was up 31666.67% from $60.0 million recorded in Q2 2025.
  • In the past 5 years, Immunome's Change in Acquisitions & Divestments ranged from a high of $125.0 million in Q3 2025 and a low of $15.0 million during Q1 2025